📰 Strides Group News
Page 2 - Strides Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Strides Group. Real-time updates on events, politics, business and more.
March 11, 2021
Updated Mar 11, 2021 | 13:10 IST The sweeping changes in BFSI have got these ten banking biggies excited, and coming back for more. These high achievers are back in the game with new innings   All work and no play might make Jack a dull boy, but in India, it makes for some successful bankers. After decades of working as the top bosses of some of the country’s biggest banks, bringing in the digital revolution to the banking process and taking their institutions to t...
January 8, 2021
Puri, who led HDFC Bank since its inception over 25 years ago, retired in October last year Ex-banker Aditya Puri joins as advisor to pharma major Strides ANI | Updated: Jan 08, 2021 13:40 IST Strides said his appointment to the Stelis board comes at an exciting juncture for the company as it transitions from incubation phase to a consolidation and growth phase to establish itself as a partner of choice globally with the aim of bringing world-class treatmen...
January 8, 2021
Read more about Indices open on firm note; breadth strong on Business Standard. Local stocks are trading firm in early trade on buying demand in index pivotals. At 9:25 IST, the barometer index, the S&P BSE Sensex, was up 357.81 points or 0.74% at 48,451.13. The Nifty 50 index was up 112.35 points or 0.79% at 14,249.70.
January 8, 2021
Stelis poised for its next leg of growth, this is the right time to expand the board, and ensure robust guidance and governance by the best possible industry minds.
January 8, 2021
Strides Pharma Science said that Aditya Puri has joined the Strides Group as an advisor and also as a director of its associate company, Stelis Biopharma. Stelis Biopharma is a vertically integrated biopharmaceutical company. The company offers end-to-end state-of-the-art CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. A stalwart of the Indian banking and financial services industry, Aditya Puri was the founder-managing director and c...
January 8, 2021
Puri, who led HDFC Bank since its inception over 25 years ago, retired in October 2020, after a highly successful career which has made the bank the largest among private sector lenders.
January 8, 2021
Read more about TCS, Biocon, Bharat Rasayan in focus on Business Standard. Tata Consultancy Services (TCS) will declare its December 2020 quarter earnings today, 8 January 2021.
January 8, 2021
Stocks to Watch: TCS, Biocon, Tata Power, Union Bank, DHFL, HCL Tech Premium Share Via Read Full Story NEW DELHI : Here’s a list of top ten stocks that may be in news on Friday: TCS: The IT firm will announce its earnings for the quarter ended 31 December today. Tata Consultancy Services is expected to sustain the revenue momentum in Q3FY21 following an uptick in business activities. TRENDING STORIESSee All 1 min read Premium 1 min read Premium 1 min read Premium 1 min read . 08:41 AM IST ...
January 8, 2021
Former HDFC Bank MD Aditya Puri joins biopharma company Strides as advisor Aditya Puri said that he was looking forward to working with Kumar and building world-class institutions to produce high-quality affordable biotherapeutics and CDMO services BusinessToday.In | January 8, 2021 | Updated 13:51 IST Aditya Puri joins biopharma group as advisor Former HDFC Bank Managing Director Aditya Puri has joined Strides Group as Advisor and Stelis Biopharma Bengaluru as Director. "Strides Pharma Scienc...
January 8, 2021
Former HDFC Bank managing director Aditya Puri has joined global pharma major Strides Group as an advisor and will also serve as a director of its associate company Stelis Biopharma. "Eminent corporate doyen Aditya Puri joins the Strides Group as an advisor and also will be a director of its associate company, Stelis Biopharma," Strides Pharma Science Ltd said in a regulatory filing. Strides Pharma Science said Puris appointment to the Stelis board comes at an exciting juncture for the compan...